insights_auto
Kwa nini DMYD-B imeongezeka kwa 3.35%?
Fahamu zaidichevron_right
DMYD-B:STO
Diamyd Medical AB
SEK 1.05
arrow_upward
+3.35%(+0.034) Siku 1
13 Okt, 17:22:00 GMT +2 · SEK
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya DMYD-B...
Fungua
SEK 1.03
Juu
SEK 1.08
Chini
SEK 1.01
Mtaji wa soko
158.75M
Wastani wa kiasi cha mauzo
elfu 796.34
Kiasi cha mauzo ya hisa
elfu 744.90
Juu kwa wiki 52
SEK 17.88
Chini kwa wiki 52
SEK 0.90
EPS
-SEK 1.76
Hisa za wawekezaji
134.00M
Idadi ya wafanyakazi
42
Fungua
SEK 1.03
Juu
SEK 1.08
Chini
SEK 1.01
Mtaji wa soko
158.75M
Wastani wa kiasi cha mauzo
elfu 796.34
Kiasi cha mauzo ya hisa
elfu 744.90
Juu kwa wiki 52
SEK 17.88
Chini kwa wiki 52
SEK 0.90
EPS
-SEK 1.76
Hisa za wawekezaji
134.00M
Idadi ya wafanyakazi
42
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Simply Wall Street
·
dakika 2 zilizopita
Marvell Technology (MRVL) Introduced First Six Channel CXL 3.2 Memory Expanders
Benzinga
·
dakika 56 zilizopita
VERAXA Biotech (NASDAQ: VRXA) Presents First In Vivo Proof-of-Concept Data for BiTAC-ADC Platform at Worl
Stock Titan
·
saa 1 iliyopita
Nasdaq files to remove Bone Biologics (Nasdaq: BBLG) warrants from listing and/or registration.
Yahoo Finance
·
dakika 36 zilizopita
XRP Fell 8% in the Week It Got a Nasdaq Listing, a Dubai Bank Deal and an ETF Inflow. Why Did None of It Count?
Wasifu
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GAD₆₅, one of two human glutamate decarboxylase gene products.
The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in Umeå which utilizes bacuolavirus-mediated protein expression. Wikipedia
Kuhusu Diamyd Medical AB
Afisa Mkuu Mtendaji (CEO)Ulf Hannelius
Wafanyakazi42
Lilianzishwa1984
Makao makuu-
Sekta-
Tovutidiamyd.com